Adnan-Awad, Shady http://orcid.org/0000-0001-6205-7799
Kim, Daehong http://orcid.org/0000-0002-1253-8946
Hohtari, Helena http://orcid.org/0000-0002-1510-8319
Javarappa, Komal Kumar
Brandstoetter, Tania http://orcid.org/0000-0003-4037-5352
Mayer, Isabella
Potdar, Swapnil http://orcid.org/0000-0002-2778-6918
Heckman, Caroline A.
Kytölä, Soili
Porkka, Kimmo
Doma, Eszter
Sexl, Veronika
Kankainen, Matti http://orcid.org/0000-0002-4714-9481
Mustjoki, Satu http://orcid.org/0000-0002-0816-8241
Funding for this research was provided by:
Signe ja Ane Gyllenbergin Säätiö
Suomen Kulttuurirahasto
Ida Montinin Säätiö
Research grant from Incyte.
Academy of Finland (292605 and 287224)
Tekes (6113/31/2016)
S.M. has received honoraria and research funding from Novartis, Pfizer and Bristol-Myers Squibb (not related to this study).
Article History
Received: 27 July 2020
Revised: 30 September 2020
Accepted: 25 October 2020
First Online: 9 November 2020
Compliance with ethical standards
:
: This work was supported by Academy of Finland (grant no. 292605 and 287224), the Finnish Funding Agency for Innovation (Dnro 6113/31/2016), Finnish special governmental subsidy for health sciences, research and training, Signe and Ane Gyllenberg Foundation, Finnish Cultural Foundation, Ida Montin Foundation, Nordic Cancer Union, Helsinki Institute of Life Science, Cancer Foundation Finland, Relander Foundation, Incyte Nordic Hematology grant, and Finnish Cancer Institute. SM has received honoraria and research funding from Novartis, Pfizer, and Bristol-Myers Squibb (not related to this study). SAA and HH have received research funding from Incyte.